See more : Wall Financial Corporation (WFICF) Income Statement Analysis – Financial Results
Complete financial analysis of Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tianshui Zhongxing Bio-technology Co.,Ltd., a leading company in the Agricultural Farm Products industry within the Consumer Defensive sector.
- HIMACS, Ltd. (4299.T) Income Statement Analysis – Financial Results
- Global Water Resources, Inc. (GWR.TO) Income Statement Analysis – Financial Results
- Chrometco Limited (CMO.JO) Income Statement Analysis – Financial Results
- JCK International Public Company Limited (JCK.BK) Income Statement Analysis – Financial Results
- TRB Systems International Inc. (TRBX) Income Statement Analysis – Financial Results
Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ)
About Tianshui Zhongxing Bio-technology Co.,Ltd.
Tianshui Zhongxing Bio-technology Co.,Ltd. engages in the research and development, production, and sale of edible fungi in China. It offers mushrooms under the Xi Huang, Nüwa, and Zhongxing and other brands. The company was formerly known as Tianshui Zhongxing Bio-technology Ltd. and changed its name to Tianshui Zhongxing Bio-technology Co.,Ltd. in March 2012. Tianshui Zhongxing Bio-technology Co.,Ltd. was founded in 2005 and is headquartered in Tianshui, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.93B | 1.97B | 1.56B | 1.48B | 1.16B | 926.43M | 739.79M | 585.02M | 479.52M | 383.50M | 263.94M | 190.40M | 131.31M |
| Cost of Revenue | 1.49B | 1.47B | 1.27B | 1.07B | 879.53M | 668.46M | 505.87M | 356.11M | 282.06M | 237.80M | 172.71M | 99.70M | 55.43M |
| Gross Profit | 436.86M | 501.48M | 287.97M | 409.31M | 276.30M | 257.97M | 233.92M | 228.90M | 197.46M | 145.69M | 91.23M | 90.70M | 75.89M |
| Gross Profit Ratio | 22.62% | 25.45% | 18.51% | 27.60% | 23.91% | 27.85% | 31.62% | 39.13% | 41.18% | 37.99% | 34.57% | 47.64% | 57.79% |
| Research & Development | 12.92M | 10.41M | 7.17M | 7.21M | 3.44M | 3.19M | 1.31M | 1.37M | 2.17M | 3.23M | 1.95M | 1.43M | 0.00 |
| General & Administrative | 25.52M | 26.87M | 43.75M | 25.96M | 16.72M | 17.54M | 18.58M | 14.57M | 17.75M | 2.66M | 1.49M | 5.32M | 22.36M |
| Selling & Marketing | 150.01M | 159.97M | 131.92M | 120.89M | 100.78M | 118.17M | 93.56M | 51.52M | 43.33M | 33.75M | 24.77M | 16.73M | 7.50M |
| SG&A | 241.02M | 186.84M | 175.68M | 146.85M | 117.50M | 135.71M | 112.14M | 66.09M | 61.08M | 36.41M | 26.26M | 22.05M | 29.86M |
| Other Expenses | 23.99M | 33.71M | 4.54M | 31.04M | 24.84M | -1.19M | 4.08M | 8.26M | 10.59M | 6.64M | 3.69M | 3.56M | 2.64M |
| Operating Expenses | 277.94M | 230.96M | 187.38M | 185.09M | 145.78M | 168.12M | 134.24M | 93.96M | 84.64M | 55.01M | 38.64M | 28.66M | 29.86M |
| Cost & Expenses | 1.77B | 1.70B | 1.46B | 1.26B | 1.03B | 836.58M | 640.11M | 450.07M | 366.70M | 292.81M | 211.35M | 128.37M | 85.28M |
| Interest Income | 30.98M | 30.98M | 53.59M | 43.00M | 33.61M | 15.65M | 8.05M | 9.24M | 7.48M | 3.98M | 2.09M | 935.95K | -0.92 |
| Interest Expense | 83.61M | 90.49M | 80.87M | 85.55M | 74.85M | 21.76M | 2.57M | 4.79M | 15.14M | 9.71M | 3.48M | 2.55M | 5.04M |
| Depreciation & Amortization | 268.86M | 275.55M | 247.87M | 223.63M | 190.88M | 143.28M | 91.46M | 67.56M | 54.66M | 43.19M | 34.95M | 21.29M | 5.17M |
| EBITDA | 515.87M | 524.79M | 389.71M | 513.92M | 334.76M | 282.06M | 238.98M | 234.13M | 185.28M | 142.88M | 92.62M | 86.50M | 46.03M |
| EBITDA Ratio | 26.71% | 29.59% | 24.36% | 33.42% | 30.92% | 30.04% | 32.21% | 40.05% | 38.64% | 37.38% | 35.42% | 46.15% | 35.11% |
| Operating Income | 158.92M | 307.61M | 121.63M | 271.62M | 166.46M | 113.93M | 138.70M | 153.53M | 104.42M | 84.16M | 51.02M | 60.43M | 40.94M |
| Operating Income Ratio | 8.23% | 15.61% | 7.82% | 18.31% | 14.40% | 12.30% | 18.75% | 26.24% | 21.78% | 21.95% | 19.33% | 31.74% | 31.17% |
| Total Other Income/Expenses | 3.90M | -148.71M | -67.32M | -82.12M | -97.44M | -1.19M | 4.08M | 8.26M | 10.58M | 6.64M | 3.69M | 3.56M | 2.64M |
| Income Before Tax | 162.82M | 158.90M | 54.32M | 189.50M | 69.02M | 112.75M | 142.78M | 161.34M | 115.01M | 90.81M | 54.70M | 63.99M | 43.58M |
| Income Before Tax Ratio | 8.43% | 8.06% | 3.49% | 12.78% | 5.97% | 12.17% | 19.30% | 27.58% | 23.98% | 23.68% | 20.72% | 33.61% | 33.18% |
| Income Tax Expense | 3.26M | 4.06K | 66.67M | 82.66M | 98.06M | 44.65M | 47.68M | 34.64M | 18.41M | 9.40M | 5.88M | 4.54M | -5.10M |
| Net Income | 159.58M | 158.35M | -12.35M | 106.84M | -29.03M | 111.94M | 142.27M | 158.51M | 114.38M | 90.88M | 54.75M | 63.99M | 43.58M |
| Net Income Ratio | 8.26% | 8.04% | -0.79% | 7.20% | -2.51% | 12.08% | 19.23% | 27.09% | 23.85% | 23.70% | 20.74% | 33.61% | 33.18% |
| EPS | 0.41 | 0.40 | -0.03 | 0.32 | -0.08 | 0.31 | 0.39 | 0.49 | 0.43 | 0.39 | 0.24 | 0.29 | 1.36 |
| EPS Diluted | 0.41 | 0.40 | -0.03 | 0.32 | -0.08 | 0.30 | 0.38 | 0.47 | 0.41 | 0.39 | 0.24 | 0.29 | 1.36 |
| Weighted Avg Shares Out | 393.24M | 392.92M | 387.49M | 337.43M | 360.02M | 361.09M | 364.80M | 323.49M | 267.31M | 230.14M | 229.18M | 222.48M | 407.42M |
| Weighted Avg Shares Out (Dil) | 393.24M | 392.92M | 387.49M | 337.43M | 360.02M | 373.13M | 374.40M | 337.26M | 281.45M | 230.15M | 229.20M | 222.48M | 407.42M |
Source: https://incomestatements.info
Category: Stock Reports